Navigation Links
PDL BioPharma Elects Barry Selick to Its Board of Directors
Date:8/3/2009

INCLINE VILLAGE, Nev., Aug. 3 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced the appointment of Harold E. ("Barry") Selick, Ph.D., to the Company's Board of Directors.

"Barry's experience as a seasoned biotechnology executive and his extensive knowledge of PDL's humanization technology will allow him to make valuable contributions to our strategy and operations as we seek to maximize the value of our antibody humanization patents and related assets and monetize these assets for our stockholders," said John McLaughlin, president and chief executive officer of PDL.

Dr. Selick has served as chief executive officer of Threshold Pharmaceuticals since June 2002. From January 1999 to April 2002, he was chief executive officer of biotechnology company Camitro Corporation. From 1992 to 1999, he worked at Affymax Research Institute, the drug discovery technology development center for Glaxo Wellcome plc, most recently as vice president of Research. Prior to joining Affymax, he held scientific positions at Protein Design Labs, Inc. and Anergen, Inc. As a staff scientist at Protein Design Labs, he was a co-inventor of the technology underlying the creation of fully humanized antibody therapeutics and applied this technology to PDL's first product, Zenapax (R), which was developed and commercialized by Roche for the prevention of kidney transplant rejection. Dr. Selick received his B.S. and Ph.D. from the University of Pennsylvania and was a Damon Runyon-Walter Winchell Cancer Fund Fellow and an American Cancer Society Senior Fellow at the University of California, San Francisco.

About PDL BioPharma, Inc.

PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatme
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
2. PDL BioPharma Announces Second Quarter 2009 Financial Results
3. PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009
4. DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller
5. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
6. Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
7. Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series
8. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
9. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
10. PDL BioPharma Announces Record Date for October 1 Dividend Payment
11. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back ... hip pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received ... went on to earn his title of Doctor of Chiropractic from the Palmer College ...
(Date:8/28/2015)... ... August 28, 2015 , ... Northridge dentists Dr. Elyson ... For just $199, patients can currently receive a one hour treatment of this teeth ... but it includes a number of unique features that can turn teeth up to ...
(Date:8/28/2015)... La Mirada, Ca (PRWEB) , ... August 28, ... ... are now administering medical evaluations for those seeking to go deep sea diving. ... pressure, possible oxygen toxicity, and decompression sickness; for these reasons, it is vital ...
(Date:8/28/2015)... Washington, DC (PRWEB) , ... ... ... Atlantic Information Services, Inc.’s (AIS) Medicare-Medicaid Dual Eligibles Database have added comprehensive ... newest CMS-backed alignment demonstration approved for a December 2015 launch; and Idaho’s ...
(Date:8/28/2015)... ... ... External Counterpulsation, also known as ECP or EECP, is a proven treatment ... ECP) machines with a full clinic licence to help people prevent and reverse heart ... prevent and reverse heart disease through its evidence-based integrative approach to heart ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Healthpointe Now Offering Scuba Physicals 2Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2
... research center focused,on improving the quality of life of ... Chattanooga, led by a world-renowned researcher whose,concepts and tools ... The Siskin Center for Child and Family Research ... nonprofit organization focused,on education, outreach and support for children ...
... DIEGO, Dec. 3 Cardium Therapeutics,(Amex: ... presenting a webcast providing,an investor presentation, corporate update ... The webcast will be presented following the ... and can be accessed at, http://www.investorcalendar.com/IC/CEPage.asp?ID=138418 at ...
... place objects in the wound, researchers say , , ... disorder where people wound themselves and then place ... among American teens, especially girls, researchers say. , ... Radiological Society of North America,s annual meeting in ...
... 3 NewCardio, Inc.,(OTC Bulletin Board: NWCI) a cardiac ... a restructure of the going-forward terms of,its December 27, ... investors,in the transaction have exercised a portion of their ... sheet. This will extend the,Company,s cash reserves to ...
... of New York State,s Metro Services has chosen BRANDEMiX, the NYC-based ... brand and launch an employee communications campaign in support of their ... ... December 3, 2008 -- The Cerebral Palsy Associations of New York ...
... their family and friends put their feet where their mouths were on ... charity in the inaugural HBA Great Australian Run. , ... Melbourne, VIC ... employees and their family and friends put their feet where their mouths ...
Cached Medicine News:Health News:Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education 2Health News:Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education 3Health News:Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education 4Health News:Cardium Announces Investor Presentation and Corporate Update Webcast 2Health News:'Self-Embedding' a Troubling Trend Among Teens 2Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 2Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 3Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 4Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 5Health News:NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure 6Health News:BRANDEMiX Selected to Launch Cerebral Palsy Associations of NYS Metro Services New Strategic Plan 2Health News:HBA People Walk the Talk for Better Health in the HBA Great Australian Run 2
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Developed by Pharmacia ... prostaglandin receptor agonist which effectively reduces intraocular pressure. ... FDA, latanoprost (under the trade name of Xalatan) ...
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... MYL ) shareholder vote regarding its planned unsolicited ... Mylan,s offer to Perrigo shareholders have always been, and ... reflection of the value available to Perrigo shareholders, and ... has allowed its shareholders to consider," said Joseph ...
(Date:8/28/2015)... 28, 2015 , Joint research by ... from Biostar , Published in ,Stem Cells Translational ... lifespan through multiple IV administration of Adipose-derived MSC ... expectancy found , Commercialization within 5 years expected ... possibility that adult mesenchymal stem cells (MSCs) may extend ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
... China, May 23, 2012 /PRNewswire-Asia/ -- China Botanic ... ("China Botanic" or the "Company"), a developer, manufacturer ... Chinese Medicines ("TCM") in China, today announced that ... and Export Fair (the "Canton Fair") held in ...
... 23, 2012 Reportlinker.com announces that a new ... The Medical Device Market: ... Summary Espicom,s in-depth medical ... to understand the key drivers in medical markets ...
Cached Medicine Technology:China Botanic Attends the 111th China Import and Export Fair 2China Botanic Attends the 111th China Import and Export Fair 3The Medical Device Market: USA 2The Medical Device Market: USA 3The Medical Device Market: USA 4The Medical Device Market: USA 5The Medical Device Market: USA 6The Medical Device Market: USA 7The Medical Device Market: USA 8
...
...
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen....
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Medicine Products: